|
1 Indications And Usage Nucala Is An Interleukin-5 (Il-5) Antagonist Monoclonal Antibody (Igg1 Kappa) Indicated For: • Add-On Maintenance Treatment Of Patients With Severe Asthma Aged 6 Years And Older, And With An Eosinophilic Phenotype. ( 1.1 ) • The Treatment Of Adult Patients With Eosinophilic Granulomatosis With Polyangiitis (Egpa). ( 1.2 ) Limitations Of Use: Not For Relief Of Acute Bronchospasm Or Status Asthmaticus. ( 1.1 ) 1.1 Maintenance Treatment Of Severe Asthma Nucala Is Indicated For The Add-On Maintenance Treatment Of Patients With Severe Asthma Aged 6 Years And Older, And With An Eosinophilic Phenotype [See Use In Specific Populations (8.4), Clinical Studies ( 14.1 )] . Limitations Of Use Nucala Is Not Indicated For The Relief Of Acute Bronchospasm Or Status Asthmaticus. 1.2 Eosinophilic Granulomatosis With Polyangiitis Nucala Is Indicated For The Treatment Of Adult Patients With Eosinophilic Granulomatosis With Polyangiitis (Egpa) .
|